MAY 24, 2019 1:02 PM PDT

What do parasitic fish have to do with cancer?

Have you ever seen a lamprey up close? If you haven’t, you should probably count your blessings, because these fish are terrifying to look at. With their jawless, tooth-filled mouths, a lamprey, which is a parasitic fish that resembles and eel and feeds on the blood of other fish, is enough to induce nightmares in adult humans.

Yet new research published in Science Advances suggests that lampreys might be the perfect vehicle for drugs that treat brain tumors, cancer, and even stroke. The research comes from a team of scientists at the University of Wisconsin-Madison and the University of Texas at Austin and analyzes a type of molecule from the immune system of lampreys, called "variable lymphocyte receptors" (VLRs).

VLRs are unique in their capacity to reach the extracellular matrix or ECM (think back to high school biology class!). "Similar to water soaking into a sponge, the lamprey molecules will potentially accumulate much more of the drug in the abundant matrix around cells compared to specific delivery to cells," explained co-author Professor John Kuo.

Because ECM networks compose a significant part of the central nervous system, the researchers think that VLRs are capable of transporting drugs to the brain more effectively for treatments for brain conditions, particularly in scenarios where the brain-blood barrier has been affected.

(Quick side note: in case you haven’t heard of the brain-blood barrier, it is a physiological aspect that stops potentially harmful agents leaking into the brain but also, therefore does not allow drugs to easily penetrate the brain. In the case of some health situations where the brain is affected, the brain-blood barrier becomes more permeable, which can lead to other problems but on the flip side but also allows drugs to get in.)

"Molecules like this [VLRs] normally couldn't ferry cargo into the brain, but anywhere there's a blood-brain barrier disruption, they can deliver drugs right to the site of pathology," explains lead author Professor Eric Shusta.

A lamprey, in all its glory. Photo: Phys.org

The researchers conducted their investigations on mouse models of glioblastoma, an aggressive form of brain cancer. They found that mice that received treatment of VLRs bound to doxorubicin, a drug used to treat this cancer, resulted in prolonged survival of the individuals. While more research is needed on this topic, the investigators are hopeful about what their findings could mean for future treatment methods.

Sources: Medical News Today, Science Advances

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
SEP 11, 2020
Cancer
Targeting Senescence in the Peripheral Nervous System to Fight Toxicity
SEP 11, 2020
Targeting Senescence in the Peripheral Nervous System to Fight Toxicity
Chemotherapy is a life-saving discovery for cancer patients. One of its biggest drawbacks is the toxicity that comes wit ...
SEP 16, 2020
Cancer
I'm addicted to the sun, are you?
SEP 16, 2020
I'm addicted to the sun, are you?
New research published in the Journal of Investigative Dermatology reports evidence that some people are geneticall ...
SEP 23, 2020
Cancer
Can Increased Pain Indicate Oral Cancer?
SEP 23, 2020
Can Increased Pain Indicate Oral Cancer?
The human body has many ways of letting you know something is wrong. It can send signals to tell you that you are hungry ...
OCT 08, 2020
Immunology
Immuno Metabolic Complexity and Modulating Metabolites
OCT 08, 2020
Immuno Metabolic Complexity and Modulating Metabolites
Immunometabolism is a relatively new subspecialty of immunology as we’ve begun to unravel the complex metabolic re ...
OCT 13, 2020
Immunology
Early Tips For Cell & Gene Therapy Regulatory Compliance
OCT 13, 2020
Early Tips For Cell & Gene Therapy Regulatory Compliance
Cell and gene therapies hold great promise for improved health outcomes. Now is the time to advance life-saving research ...
OCT 12, 2020
Drug Discovery & Development
Researchers Solve Key Problem for Cancer Immunotherapy
OCT 12, 2020
Researchers Solve Key Problem for Cancer Immunotherapy
Cancer immunotherapies are becoming increasingly promising as a standard-of-care treatment. However, despite their promi ...
Loading Comments...